CLC number: R734.2
On-line Access: 2024-08-27
Received: 2023-10-17
Revision Accepted: 2024-05-08
Crosschecked: 2013-05-22
Cited: 2
Clicked: 8744
Guo-dong Xu, Xin-bao Shi, Le-bo Sun, Qing-yun Zhou, Da-wei Zheng, Huo-shun Shi, Yong-liang Che, Zi-shan Wang, Guo-feng Shao. Down-regulation of eIF5A-2 prevents epithelial-mesenchymal transition in non-small-cell lung cancer cells[J]. Journal of Zhejiang University Science B,in press.Frontiers of Information Technology & Electronic Engineering,in press.https://doi.org/10.1631/jzus.B1200200 @article{title="Down-regulation of eIF5A-2 prevents epithelial-mesenchymal transition in non-small-cell lung cancer cells", %0 Journal Article TY - JOUR
Darkslateblue:Affiliate; Royal Blue:Author; Turquoise:Article
Reference[1]Chen, W., Luo, J.H., Hua, W.F., Zhou, F.J., Lin, M.C., Kung, H.F., Xie, D., 2009. Overexpression of EIF-5A2 is an independent predictor of outcome in patients of urothelial carcinoma of the bladder treated with radical cystectomy. Cancer Epidemiol. Biomarkers Prev., 18(2):400-408. ![]() [2]Clement, P.M., Hanauske-Abel, H.M., Wolff, E.C., Kleinman, H.K., Park, M.H., 2002. The antifungal drug ciclopirox inhibits deoxyhypusine and proline hydroxylation, endothelial cell growth and angiogenesis in vitro. Int. J. Cancer, 100(4):491-498. ![]() [3]Clement, P.M., Henderson, C.A., Jenkins, Z.A., Smit-McBride, Z., Wolff, E.C., Hershey, J.W., Johansson, H.E., 2003. Identification and characterization of eukaryotic initiation factor 5A-2. Eur. J. Biochem., 270(21):4254-4263. ![]() [4]Clement, P.M., Johansson, H.E., Wolff, E.C., Park, M.H., 2006. Differential expression of eIF5A-1 and eIF5A-2 in human cancer cells. FEBS J., 273(6):1102-1114. ![]() [5]Grünert, S., Jechlinger, M., Beug, H., 2003. Diverse cellular and molecular mechanisms contribute to epithelial plasticity and metastasis. Nat. Rev. Mol. Cell Biol., 4(8):657-665. ![]() [6]Guan, X.Y., Fung, J.M., Ma, N.F., Lau, S.H., Tai, L.S., Xie, D., Sham, J.S., 2004. Oncogenic role of eIF-5A2 in the development of ovarian cancer. Cancer Res., 64(12):4197-4200. ![]() [7]He, L.R., Zhao, H.Y., Li, B.K., Liu, Y.H., Liu, M.Z., Guan, X.Y., Xie, D., 2011. Overexpression of eIF5A-2 is an adverse prognostic marker of survival in stage I non-small cell lung cancer patients. Int. J. Cancer, 129(1):143-150. ![]() [8]Jemal, A., Siegel, R., Ward, E., Hao, Y., Xu, J., Murray, T., Thun, M.J., 2008. Cancer statistics, 2008. CA Cancer J. Clin., 58(2):71-96. ![]() [9]Kasai, H., Allen, J.T., Mason, R.M., Kamimura, T., Zhang, Z., 2005. TGF-β1 induces human alveolar epithelial to mesenchymal cell transition (EMT). Respir. Res., 6(1):56. ![]() [10]Kim, J.H., Jang, Y.S., Eom, K.S., Hwang, Y.I., Kang, H.R., Jang, S.H., Kim, D.G., 2007. Transforming growth factor β1 induces epithelial-to-mesenchymal transition of A549 cells. J. Korean Med. Sci., 22(5):898-904. ![]() [11]Li, A.L., Li, H.Y., Jin, B.F., Ye, Q.N., Zhou, T., Yu, X.D., Zhang, X.M., 2004. A novel eIF5A complex functions as a regulator of p53 and p53-dependent apoptosis. J. Biol. Chem., 279(47):49251-49258. ![]() [12]Maitah, M.Y., Ali, S., Ahmad, A., Gadgeel, S., Sarkar, F.H., 2011. Up-regulation of sonic hedgehog contributes to TGF-β1-induced epithelial to mesenchymal transition in NSCLC cells. PLoS One, 6(1):e16068. ![]() [13]Nishimura, K., Murozumi, K., Shirahata, A., Park, M.H., Kashiwagi, K., Igarashi, K., 2005. Independent roles of eIF5A and polyamines in cell proliferation. Biochem. J., 385(Pt3):779-785. ![]() [14]Nozawa, N., Hashimoto, S., Nakashima, Y., Matsuo, Y., Koga, T., Sugio, K., Sueishi, K., 2006. Immunohistochemical α- and β-catenin and E-cadherin expression and their clinicopathological significance in human lung adenocarcinoma. Pathol. Res. Pract., 202(9):639-650. ![]() [15]Rosell, R., Felip, E., Taron, M., Majo, J., Mendez, P., Sanchez-Ronco, M., Maestre, J., 2004. Gene expression as a predictive marker of outcome in stage IIB-IIIA-IIIB non-small cell lung cancer after induction gemcitabine-based chemotherapy followed by resectional surgery. Clin. Cancer Res., 10(12):4215s-4219s. ![]() [16]Saito, R.A., Watabe, T., Horiguchi, K., Kohyama, T., Saitoh, M., Nagase, T., Miyazono, K., 2009. Thyroid transcription factor-1 inhibits transforming growth factor-β-mediated epithelial-to-mesenchymal transition in lung adenocarcinoma cells. Cancer Res., 69(7):2783-2791. ![]() [17]Tang, D.J., Dong, S.S., Ma, N.F., Xie, D., Chen, L., Fu, L., Guan, X.Y., 2010. Overexpression of eukaryotic initiation factor 5A2 enhances cell motility and promotes tumor metastasis in hepatocellular carcinoma. Hepatology, 51(4):1255-1263. ![]() [18]Thiery, J.P., 2002. Epithelial-mesenchymal transitions in tumour progression. Nat. Rev. Cancer, 2(6):442-454. ![]() [19]Wozniak, A.J., Gadgeel, S.M., 2007. Adjuvant treatment of non-small-cell lung cancer: how do we improve the cure rates further? Oncology, 21(2):163-171. ![]() [20]Xie, D., Ma, N.F., Pan, Z.Z., Wu, H.X., Liu, Y.D., Wu, G.Q., Guan, X.Y., 2008. Overexpression of EIF-5A2 is associated with metastasis of human colorectal carcinoma. Hum. Pathol., 39(1):80-86. ![]() [21]Yang, G.F., Xie, D., Liu, J.H., Luo, J.H., Li, L.J., Hua, W.F., Guan, X.Y., 2009. Expression and amplification of eIF-5A2 in human epithelial ovarian tumors and overexpression of EIF-5A2 is a new independent predictor of outcome in patients with ovarian carcinoma. Gynecol. Oncol., 112(2):314-318. ![]() Journal of Zhejiang University-SCIENCE, 38 Zheda Road, Hangzhou
310027, China
Tel: +86-571-87952783; E-mail: cjzhang@zju.edu.cn Copyright © 2000 - 2025 Journal of Zhejiang University-SCIENCE |
Open peer comments: Debate/Discuss/Question/Opinion
<1>